PEIJIA-B: The Sutra Hemi-valve transcatheter mitral valve repair system has been applied for the first time in a clinical trial with human implantation

智通财经
2025.09.11 11:39

沛嘉医疗-B 宣布，其战略投资公司 Sutra Medical, Inc.成功完成 Sutra Hemi-valve 经导管二尖瓣修复系统的首次人体临床试验植入。该手术在新西兰怀卡托医院进行，针对一名 83 岁高风险患者，因严重功能性二尖瓣反流而无法采用传统治疗方案。患者恢复良好，第三天出院。

智通财经 APP 讯，沛嘉医疗-B(09996) 公布，最近，Sutra Medical, Inc.(Sutra)(该集团持有战略投资的公司) 成功完成其 Sutra Hemi-valve 经导管二尖瓣修复系统第一次应用于人体 (FIM) 的临床试验首例植入。该手术于新西兰怀卡托医院对一名患有严重功能性二尖瓣反流的 83 岁高风险患者进行，传统治疗方案不适用于该情况。患者恢复良好，于第三天出院。

Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.